DE69031879T2 - Pharmazeutisches Mittel zur Behandlung von mit Herpes-Zoster assoziierten Schmerzen und von postherpetischen Neuralgien mittels lokaler Anwendung von Lokalanästhetika - Google Patents

Pharmazeutisches Mittel zur Behandlung von mit Herpes-Zoster assoziierten Schmerzen und von postherpetischen Neuralgien mittels lokaler Anwendung von Lokalanästhetika

Info

Publication number
DE69031879T2
DE69031879T2 DE69031879T DE69031879T DE69031879T2 DE 69031879 T2 DE69031879 T2 DE 69031879T2 DE 69031879 T DE69031879 T DE 69031879T DE 69031879 T DE69031879 T DE 69031879T DE 69031879 T2 DE69031879 T2 DE 69031879T2
Authority
DE
Germany
Prior art keywords
pain associated
local
treatment
pharmaceutical agent
herpes zoster
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69031879T
Other languages
English (en)
Other versions
DE69031879D1 (de
Inventor
Harry Hind
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hind Health Care Inc
Original Assignee
Hind Health Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23267622&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69031879(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hind Health Care Inc filed Critical Hind Health Care Inc
Publication of DE69031879D1 publication Critical patent/DE69031879D1/de
Application granted granted Critical
Publication of DE69031879T2 publication Critical patent/DE69031879T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69031879T 1989-03-17 1990-03-15 Pharmazeutisches Mittel zur Behandlung von mit Herpes-Zoster assoziierten Schmerzen und von postherpetischen Neuralgien mittels lokaler Anwendung von Lokalanästhetika Expired - Lifetime DE69031879T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32537389A 1989-03-17 1989-03-17

Publications (2)

Publication Number Publication Date
DE69031879D1 DE69031879D1 (de) 1998-02-12
DE69031879T2 true DE69031879T2 (de) 1998-05-20

Family

ID=23267622

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69031879T Expired - Lifetime DE69031879T2 (de) 1989-03-17 1990-03-15 Pharmazeutisches Mittel zur Behandlung von mit Herpes-Zoster assoziierten Schmerzen und von postherpetischen Neuralgien mittels lokaler Anwendung von Lokalanästhetika

Country Status (9)

Country Link
US (2) US5601838A (de)
EP (1) EP0388306B1 (de)
JP (1) JP2515902B2 (de)
AT (1) ATE161735T1 (de)
CA (1) CA1338779C (de)
DE (1) DE69031879T2 (de)
DK (1) DK0388306T3 (de)
ES (1) ES2110963T3 (de)
GR (1) GR3026364T3 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380754A (en) * 1988-02-29 1995-01-10 Virotex Corporation Topical composition enhancing healing of viral lesions
CA1338779C (en) * 1989-03-17 1996-12-10 Harry Hind Method for treating pain associated with herpes-zoster and post-herpetic neuralgia by topical application of local anesthetics
US5411738A (en) 1989-03-17 1995-05-02 Hind Health Care, Inc. Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
JP3115625B2 (ja) * 1991-03-30 2000-12-11 帝國製薬株式会社 リドカイン含有外用貼付剤
WO1993000114A1 (en) * 1991-06-20 1993-01-07 Viro-Tex Corporation Topical composition enhancing healing of herpes lesions
US6248788B1 (en) 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
US6239180B1 (en) 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
GB9808015D0 (en) * 1998-04-15 1998-06-17 United Medical And Dental Scho Protection of the nervous system from the effects of inflammatory disease
US7565905B2 (en) * 1998-06-03 2009-07-28 Scott Laboratories, Inc. Apparatuses and methods for automatically assessing and monitoring a patient's responsiveness
US20030045500A1 (en) * 1998-07-09 2003-03-06 Leslie Magnus Pharmaceutical composition containing GABA analogs and an antiviral agent to treat shingles
JP3159688B2 (ja) * 1998-10-05 2001-04-23 祐徳薬品工業株式会社 経皮吸収テープ剤
US6383511B1 (en) * 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
US6560483B1 (en) 2000-10-18 2003-05-06 Minnesota High-Tech Resources, Llc Iontophoretic delivery patch
US6899897B2 (en) 2001-06-18 2005-05-31 Jaleva, Inc. Gum resin as a carrier for topical application of pharmacologically active agents
US6528076B2 (en) 2001-07-06 2003-03-04 Magic Herb Corp. Topical compositions and methods for treating pain
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
CN100586499C (zh) * 2002-02-20 2010-02-03 斯科特实验室公司 镇静及止痛系统
US20040076671A1 (en) * 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
EP1622554A4 (de) * 2003-05-15 2008-01-02 Bioform Medical Inc Zusammensetzungen mit einer kombination aus einem pharmazeutischen mittel oder einem kosmetischen mittel und einem eine oxy-gruppe tragenden aromatischen aldehyd
US20050123484A1 (en) * 2003-10-02 2005-06-09 Collegium Pharmaceutical, Inc. Non-flammable topical anesthetic liquid aerosols
US20050112183A1 (en) * 2003-11-25 2005-05-26 Galer Bradley S. Compositions and methods for treating neuropathic sensory loss
US7666914B2 (en) * 2004-06-03 2010-02-23 Richlin David M Topical preparation and method for transdermal delivery and localization of therapeutic agents
WO2007050543A2 (en) 2005-10-24 2007-05-03 Collegium Pharmaceutical, Inc. Topical pharmaceutical foam composition
US7848801B2 (en) 2005-12-30 2010-12-07 Tti Ellebeau, Inc. Iontophoretic systems, devices, and methods of delivery of active agents to biological interface
AU2007325918B2 (en) 2006-11-03 2013-10-17 Durect Corporation Transdermal delivery systems comprising bupivacaine
CN101801359B (zh) * 2007-05-18 2013-11-06 Tti优而美株式会社 确保有效成分经生物界面增加释放的透皮递送设备
AU2008289109B2 (en) * 2007-08-17 2012-02-02 Centrexion Therapeutics Corporation High concentration local anesthetic formulations
WO2010019953A1 (en) 2008-08-15 2010-02-18 Arcion Therapeutics, Inc. High concentration local anesthetic formulations for treating non-neuropathic pain
JP5472756B2 (ja) 2008-10-02 2014-04-16 マイラン・インク 多層接着ラミネートの作製方法
EP2560626A4 (de) * 2010-04-21 2013-09-18 Teikoku Pharma Usa Inc Emulsionszusammensetzungen für lokalanästhesie sowie verfahren zu ihrer herstellung und verwendung
SG10202009963PA (en) 2011-01-07 2020-11-27 Allergan Inc Melanin modification compositions and methods of use
US9925264B2 (en) 2011-05-10 2018-03-27 Itochu Chemical Frontier Corporation Non-aqueous patch
EP3569227A1 (de) 2011-05-10 2019-11-20 Itochu Chemical Frontier Corporation Nichtwässriges pflaster
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
PL2823815T3 (pl) 2011-09-27 2018-10-31 Itochu Chemical Frontier Corporation Niewodny plaster
ES2961655T3 (es) 2013-01-18 2024-03-13 Kemphys Ltd Medicamento para tratamiento de enfermedad neuropática
US10603508B2 (en) 2015-10-15 2020-03-31 Dusa Pharmaceuticals, Inc. Adjustable illuminators and methods for photodynamic therapy and diagnosis
WO2017066270A1 (en) 2015-10-15 2017-04-20 Dusa Pharmaceuticals, Inc. Adjustable illuminator for photodynamic therapy and diagnosis
US10357567B1 (en) 2018-01-12 2019-07-23 Dusa Pharmaceuticals, Inc. Methods for photodynamic therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617282A1 (de) * 1965-11-30 1975-02-06 Astra Pharma Prod Vorrichtung zur lokalanaesthetisierung durch oertliche aufbringung und verfahren zur herstellung dieser vorrichtung
JPS6251617A (ja) * 1985-08-30 1987-03-06 Wako Pure Chem Ind Ltd ビダラビンゲル軟膏
JPH0794394B2 (ja) * 1986-12-24 1995-10-11 前田薬品工業株式会社 消炎鎮痛外用貼付剤
GB8712518D0 (en) * 1987-05-28 1987-07-01 Univ Belfast Unit-dose film composition
AU1834188A (en) * 1987-06-29 1989-01-05 Kendall Company, The Novel medicated dressings
EP0331392A3 (de) * 1988-03-01 1990-02-14 Alza Corporation Anästhesie und Antisepsis von Haut
US5411738A (en) * 1989-03-17 1995-05-02 Hind Health Care, Inc. Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
CA1338779C (en) * 1989-03-17 1996-12-10 Harry Hind Method for treating pain associated with herpes-zoster and post-herpetic neuralgia by topical application of local anesthetics

Also Published As

Publication number Publication date
ES2110963T3 (es) 1998-03-01
JP2515902B2 (ja) 1996-07-10
US5601838A (en) 1997-02-11
ATE161735T1 (de) 1998-01-15
EP0388306A2 (de) 1990-09-19
DK0388306T3 (da) 1998-09-07
EP0388306B1 (de) 1998-01-07
EP0388306A3 (de) 1991-03-06
DE69031879D1 (de) 1998-02-12
JPH02300138A (ja) 1990-12-12
US5709869A (en) 1998-01-20
GR3026364T3 (en) 1998-06-30
CA1338779C (en) 1996-12-10

Similar Documents

Publication Publication Date Title
DE69031879T2 (de) Pharmazeutisches Mittel zur Behandlung von mit Herpes-Zoster assoziierten Schmerzen und von postherpetischen Neuralgien mittels lokaler Anwendung von Lokalanästhetika
DE69814917D1 (de) Transdermale therapeutische vorrichtung mit capsaicin und seinen analogen
ATE185694T1 (de) Oxybutynin zur transdermalen verabreichung
DE59209860D1 (de) Linsidomin zur behandlung erektiler dysfunktionen
BR9815439A (pt) Analgesia contìnua obtida com buprenorphine
ATE51342T1 (de) Mittel und vorrichtung zur steuerung der transdermalen penetration topischer und systematischer wirkstoffe.
DE68910159D1 (de) Dosierform für Verabreichung in der Humanmedizin.
ATE202923T1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
ATE173162T1 (de) Medizinische vorrichtung zur verabreichung von aktivsubstanzen oder arzneistoffen in sehr niedriger dosis, insbesondere von homöopatischen arzneistoffen
BR8804370A (pt) Dispositivo eletroterapeutico de baixa frequencia
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
CO4970691A1 (es) Terapia en combinacion para erradicar vhc-arn detectable en pacientes que padecen infeccion de hepatitis c cronica
NZ220599A (en) Controlled release oral dosage formulation of carbidopa and levodopa
CS9001136A2 (en) Method of transdermal therapeutical system's production with active substance's graded liberation and application for active substances' local or systemic administration
DE69426530D1 (de) Pharmazeutische zusammensetzung zur förderung der gewebeheilung und -regenerierung und darreichungssatz
ATE200617T1 (de) Pharmazeutische zusammensetzungen zur transdermalen verabreichung von melatonin und/oder seine analoge
KR900701309A (ko) 액체 질소 및 재조합 DNA사람 α인터페론을 혼용하여 생식기우종을 치료하는 방법
McGlone et al. Reducing the pain of intradermal lignocaine injection by pH buffering.
KR870010871A (ko) 재조합 인체 알파 인터페론에 의한 기저세포 암종의 병소내적 치료방법
ATE281157T1 (de) Zusammensetzung enthaltend di- und trinatriumsalze von echinochrome zur behandlung von augenerkrankungen
Macaluso et al. Antibiotic iontophoresis in the treatment of burn perichondritis of the rabbit ear
EP0198003A1 (de) Zusammensetzungen zur erleichterung des hustens
RU94000695A (ru) Средство с противоаллергическим действием
ATE153533T1 (de) Zubereitungen, die acyclovir-ähnliche verbindungen und 2'-vinylsubstituierte nukleosidanaloge enthalten, zur behandlung viraler infektionen
RU94001389A (ru) Способ лечения псориаза

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee
8370 Indication related to discontinuation of the patent is to be deleted